Clearside Biomedical (CLSD) Financials

$0.71

$0.30 (73.17%)

As on 26-Dec-2025 09:30EDT

Market cap

$2 Mln

Revenue (TTM)

$3 Mln

P/E Ratio

--

P/B Ratio

3.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	3.33	1.66	8.23	1.33	29.58	7.89
Cost of Revenue	0.48	0.15	0.36	0.20	0.18	--
Gross Profit	2.85	1.52	7.87	1.12	29.58	7.89
Operating Expenses	25.81	30.40	32.72	31.40	30.20	25.83
Operating Profit (EBIT)	-22.96	-28.88	-24.84	-30.28	-0.63	-17.94
Other Income	--	--	--	0.67	1.00	-0.28
Profit before Tax	-25.28	-34.35	-32.49	-32.95	0.38	-18.21
Provision for Tax	0.72	--	-0.10	1.12	-0.06	-0.18
Profit after Tax (Net Income)	-26.00	-34.35	-32.49	-32.95	0.38	-18.03
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-32.95	0.38	-18.21

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	-53.95	-38.86	-15.91	10.61	37.98	8.76
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	62.82	59.19	43.12	34.91	0.29	0.62
Current Liabilities	2.77	4.79	6.81	5.78	4.64	9.94
Total Liabilities	14.41	25.13	34.02	51.30	42.90	19.32

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	3.39	3.85	3.89	1.90	0.77	1.20
Current Assets	8.25	21.27	30.12	49.40	42.14	18.12
Total Assets	14.41	25.13	34.02	51.30	42.90	19.32
Total Debt*	0.45	52.47	43.00	35.26	0.68	1.98
Net Current Assets	5.48	16.48	23.31	43.62	37.50	8.18

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-24.70	-18.14	-13.37	-10.73	-13.12
Cash Flow from Investing Activities	--	-0.64	-1.78	-0.25	-0.25	-0.06
Cash from Financing Activities	--	16.44	0.41	31.33	23.78	7.87
Net Cash Inflow / Outflow	--	--	--	17.72	13.05	-5.31

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-5.06	-6.79	-7.81	-8.18	0.09	-5.51
Cash EPS ($)	--	-6.75	-7.79	-8.14	0.14	-5.46
Adjusted Book Value ($)	--	--	--	2.63	9.31	2.68
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-4.88	-4.36	-3.32	-2.63	-4.01
Free Cash Flow per Share ($)	--	-5.08	-4.79	-3.38	-2.63	-4.03

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-168.79	-89.05	-77.96	1.52	-127.38
ROE (%)	--	125.45	1,224.69	-135.63	1.61	-181.02
ROA (%)	-105.75	-116.16	-76.15	-69.95	1.21	-78.22
EBIT Margin (%)	-441.48	-1,476.74	-281.12	-2,231.20	1.27	-227.20
Net Margin (%)	-780.90	-2,064.42	-394.91	-1,650.65	1.23	-236.65
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	-56.78	-0.80	5.20	-0.96	2.75	2.63
EBIT Growth (%)	34.39	-6.26	21.90	-7,974.47	102.10	40.82
Net Profit Growth (%)	18.45	-5.75	1.40	-8,862.50	102.09	41.00
EPS Growth (%)	25.15	0.13	0.05	-89.74	1.02	0.49
Book Value Growth (%)	-47.64	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-0.14	-0.15	-0.14	29.83	-0.50
Price / Book Value	3.93	-0.12	-0.31	0.43	0.30	1.02
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.84	-1.53	-0.82	0.29	-33.47	0.36
Close Price ($)	3.97	14.25	17.55	16.80	41.25	41.10
High Price ($)	24.75	31.80	27.75	44.25	115.95	61.95
Low Price ($)	3.32	12.02	9.75	14.70	33.15	16.50
Market Cap ($ Cr)	2.15	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	-1.35	-2.70	3.32	0.02	0.23
Short term debt to equity ratio	-0.01	-0.01	-0.02	0.03	0.01	0.16
Current Ratio	2.98	4.44	4.42	8.54	9.08	1.82
Quick Ratio	2.98	--	4.42	--	8.88	--
Interest Coverage	-1.39	-2.51	-2.47	-8.87	0.37	-53.54

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	7.99	30.47	2.07	--	33.81	--
Asset Turnover	0.14	0.06	0.19	0.03	0.95	0.34
Receivable days	--	74.30	3.77	1,376.22	61.75	--
Inventory Days	--	0.00	0.00	1,649.00	1,889.86	--
Payable days	--	4,482.28	1,674.49	1,782.38	3,014.34	--
Cash Conversion Cycle	--	-4,407.98	-1,670.72	1,242.84	-1,062.73	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.